Philippe Masson

Title: Inventor Philippe Masson: Innovating in Neurodegenerative Treatments

Introduction

Philippe Masson, based in Hauteville les Dijon, France, is a notable inventor recognized for his significant contributions to pharmaceutical innovations. With a unique patent to his name, he has focused on developing essential compounds aimed at treating various medical conditions.

Latest Patents

Philippe Masson holds one patent concerning LXR receptor modulators. His invention encompasses benzenesulfonamide derivative compounds, which are represented by a general formula and include their pharmaceutically acceptable addition salts. The patent elaborates on the formulation methods for such compounds and their application in pharmaceutical compositions. Notably, these compounds serve as pharmacologically active substances, particularly targeting neurodegenerative diseases, cardiovascular issues, inflammatory diseases, hypercholesterolemia, and diabetes.

Career Highlights

Philippe is currently affiliated with Laboratories Fournier S.A. Throughout his career, he has dedicated himself to research aimed at enhancing therapeutic strategies for various diseases, contributing to the advancement of pharmaceutical sciences through his innovative ideas and creations.

Collaborations

In his professional journey, Philippe Masson has collaborated with esteemed colleagues, including Luc Lebreton and Christine Massardier. Together, they have worked on an array of projects that underline the importance of teamwork in driving innovation in the field of pharmaceuticals.

Conclusion

Philippe Masson's contributions to the field of medicine through his inventions mark a significant step forward in addressing critical health issues. His patent on LXR receptor modulators exemplifies the vital role of innovation in developing effective treatments for challenging medical conditions. As he continues his work at Laboratories Fournier, his future endeavors promise to further enhance the landscape of pharmaceutical advancements.